OTC Pharmaceuticals - Europe

  • Europe
  • Revenue in the OTC Pharmaceuticals market amounts to €49.77bn in 2024. The market is expected to grow annually by 3.91% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €14.22bn in 2024.
  • In global comparison, most revenue is generated in the United States (€37,700m in 2024).
  • In relation to total population figures, per person revenues of €58.98 are generated in 2024.
  • In the OTC Pharmaceuticals market, 15.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Comparación de regiones

Analyst Opinion

The OTC Pharmaceuticals market in Europe is experiencing steady growth and development due to various factors such as changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences:
Customers in Europe are increasingly opting for self-medication and over-the-counter (OTC) pharmaceutical products for minor health issues. This preference can be attributed to the convenience and accessibility of OTC products, as they can be purchased without a prescription and are readily available in pharmacies and supermarkets. Additionally, customers are becoming more health-conscious and proactive in managing their well-being, leading to a growing demand for OTC products that cater to specific health needs such as vitamins, supplements, and pain relief medications.

Trends in the market:
One prominent trend in the OTC Pharmaceuticals market in Europe is the increasing popularity of natural and herbal remedies. Customers are seeking alternative and holistic approaches to healthcare, which has led to a rise in demand for OTC products that are derived from natural ingredients and have minimal side effects. This trend aligns with the overall shift towards wellness and preventive healthcare in Europe. Another trend in the market is the growing focus on personalized medicine. Customers are looking for OTC products that are tailored to their specific needs and preferences. This has led to the development of niche OTC products targeting specific demographics such as children, women, and the elderly. Manufacturers are also investing in research and development to create innovative OTC products that address specific health concerns, such as sleep aids, digestive health, and stress relief.

Local special circumstances:
Each country in Europe has its own unique set of regulations and healthcare systems, which can impact the OTC Pharmaceuticals market. For example, some countries have stricter regulations on the sale and advertising of OTC products, while others have more lenient regulations. These differences can affect the availability and accessibility of OTC products in different markets. Furthermore, cultural and societal factors can also influence customer preferences and purchasing behavior. For instance, in some European countries, there is a strong tradition of using herbal remedies and natural therapies, which can drive the demand for OTC products in these categories.

Underlying macroeconomic factors:
The OTC Pharmaceuticals market in Europe is influenced by macroeconomic factors such as population growth, disposable income levels, and healthcare expenditure. As the population in Europe continues to grow and age, there is an increased demand for OTC products that cater to the health needs of elderly individuals. Moreover, rising disposable incomes and increased healthcare expenditure contribute to the affordability and accessibility of OTC products, further driving market growth. In conclusion, the OTC Pharmaceuticals market in Europe is developing and growing due to changing customer preferences, emerging market trends, local special circumstances, and underlying macroeconomic factors. The increasing popularity of self-medication, natural remedies, and personalized medicine are shaping the market landscape in different European countries. Additionally, regulatory differences and cultural factors play a role in influencing customer preferences and market dynamics. Overall, the OTC Pharmaceuticals market in Europe is expected to continue its growth trajectory in the coming years.


Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.


In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Visión general

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Espere, por favor


¿Alguna duda? Estaremos encantados de atenderte.
Statista Locations
Contacto Nerea Marcos
Nerea Marcos
Client Success Manager

Lu - vi, 9:30 - 17:00 h (CET)

Contacto Meredith Alda
Meredith Alda
Sales Manager– Contacto (Estados Unidos)

Lu - vi, 9:00 - 18:00 h (EST)

Contacto Yolanda Mega
Yolanda Mega
Operations Manager– Contacto (Asia)

Lu - vi, 9:00 - 17:00 h (SGT)

Contacto Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contacto (Asia)

Lu - vi, 10:00 - 18:00 h (JST)

Contacto Lodovica Biagi
Lodovica Biagi
Director of Operations– Contacto (Europa)

Lu - vi, 9:30 - 17:00 h (GMT)

Contacto Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contacto (América Latina)

Lu - vi, 9:00am-6:00pm (EST)